Phospholipase A2-dependent effects of the venom from the new guinean small-eyed snake Micropechis ikaheka
Sanjaya Kuruppu BTech
Monash Venom Group, Department of Pharmacology, Building 13E, Monash University, Victoria 3800, Australia
Search for more papers by this authorGeoffrey K. Isbister MD
Monash Venom Group, Department of Pharmacology, Building 13E, Monash University, Victoria 3800, Australia
Search for more papers by this authorCorresponding Author
Wayne C. Hodgson PhD
Monash Venom Group, Department of Pharmacology, Building 13E, Monash University, Victoria 3800, Australia
Monash Venom Group, Department of Pharmacology, Building 13E, Monash University, Victoria 3800, AustraliaSearch for more papers by this authorSanjaya Kuruppu BTech
Monash Venom Group, Department of Pharmacology, Building 13E, Monash University, Victoria 3800, Australia
Search for more papers by this authorGeoffrey K. Isbister MD
Monash Venom Group, Department of Pharmacology, Building 13E, Monash University, Victoria 3800, Australia
Search for more papers by this authorCorresponding Author
Wayne C. Hodgson PhD
Monash Venom Group, Department of Pharmacology, Building 13E, Monash University, Victoria 3800, Australia
Monash Venom Group, Department of Pharmacology, Building 13E, Monash University, Victoria 3800, AustraliaSearch for more papers by this authorAbstract
The New Guinean small-eyed snake (Micropechis ikaheka) is a cause of life-threatening envenoming. Previous studies on M. ikaheka venom have indicated the presence of neurotoxins as well as myotoxins. This study examined the in vitro myotoxic effects of M. ikaheka venom and the efficacy of a polyvalent antivenom in neutralizing these effects. Venom (50 μg/ml) produced a slowly developing contracture and inhibition of direct twitches of the chick biventer cervicis nerve–muscle preparation in the presence of tubocurarine (10 μM). Myotoxicity was confirmed by subsequent histological examination of tissues. This myotoxicity was prevented by the prior addition of polyvalent snake antivenom (30 U/ml). However, the addition of antivenom (30 U/ml) 1 h after venom administration failed to reverse or prevent the further inhibition of direct twitches. In addition, venom (1–10 μg/ml) produced concentration-dependent contractions of the guinea-pig isolated ileum. These effects were dependent on phospholipase A2 (PLA2) activity of the venom as evidenced by the ability of the PLA2 inhibitor 4-bromophenacyl bromide (4-BPB; 1.8 mM) to prevent this activity. This study indicates that M. ikaheka venom causes significant myotoxicity and that polyvalent snake antivenom may be a potential treatment for the myotoxic effects in patients envenomed by this species. Muscle Nerve, 2005
REFERENCES
- 1 Abe T, Alema S, Miledi R. Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. Eur J Biochem 1977; 80: 1–12.
- 2 Barfaraz A, Harvey AL. The use of the chick biventer cervicis preparation to assess the protective activity of six international reference antivenoms on the neuromuscular effects of snake venoms in vitro. Toxicon 1994; 32: 267–272.
- 3 Bell KL, Kemp BK, McPherson GA, Hodgson WC. The smooth muscle relaxant effects of venom from the inland taipan (Oxyuranus microlepidotus). Toxicon 1999; 37: 229–231.
- 4 Bell KL, Sutherland SK, Hodgson WC. Some pharmacological studies of venom from the inland taipan (Oxyuranus microlepidotus). Toxicon 1998; 36: 63–74.
- 5 Crachi MT, Hammer LW, Hodgson WC. A pharmacological examination of venom from the Papuan taipan (Oxyuranus scutellatus canni). Toxicon 1999; 37: 1721–1734.
- 6
Currie BJ.
Snakebite in tropical Australia, Papua New Guinea and Irian Jaya.
Emerg Med
2000;
12:
285–294.
10.1046/j.1442-2026.2000.00150.x Google Scholar
- 7 Fatehi M, Rowan EG, Harvey AL, Harris JB. The effects of five phospholipases A2 from the venom of king brown snake, Pseudechis australis, on nerve and muscle. Toxicon 1994; 32: 1559–1572.
- 8 Fohlman J, Eaker D. Isolation and characterization of a lethal myotoxic phospholipase A from the venom of the common sea snake Enhydrina schistosa causing myoglobinuria in mice. Toxicon 1977; 15: 385–393.
- 9 Gao R, Kini RM, Gopalakrishnakone P. Purification, properties, and amino acid sequence of a hemoglobinuria-inducing phospholipase A2, MiPLA-1, from Micropechis ikaheka venom. Arch Biochem Biophys 1999; 369: 181–192.
- 10 Gao R, Kini RM, Li G, Luo R, Selvanayagam ZE, Gopalakrishnakone P. Purification and properties of three new phospholipase A2 isoenzymes from Micropechis ikaheka venom. Biochim Biophys Acta 2001; 1545: 30–40.
- 11 Gavaghan CF, Sparkes G. Delayed myotoxicity in snake envenoming by the tiger snake group. Emerg Med (Fremantle) 2003; 15: 497–499.
- 12 Geh SL, Vincent A, Rang S, Abrahams T, Jacobson L, Lang B, et al. Identification of phospholipase A2 and neurotoxic activities in the venom of the New Guinean small-eyed snake (Micropechis ikaheka). Toxicon 1997; 35: 101–109.
- 13 Gopalakrishnakone P, Ponraj D, Thwin MM. Myotoxic phospholipases from snake venoms: general myoglobinuric and local myonecrotic toxins. In: RM Kini, editor. Enzymes: structure, function and mechanism. Chichester, UK: John Wiley & Sons, Ltd.; 1997. p 511.
- 14 Gutierrez JM, Ownby CL, Odell GV. Isolation of a myotoxin from Bothrops asper venom: partial characterization and action on skeletal muscle. Toxicon 1984; 22: 115–128.
- 15 Gutierrez JM, Chaves F, Gene JA, Lomonte B, Camacho Z, Schosinsky K. Myonecrosis induced in mice by a basic myotoxin isolated from the venom of the snake Bothrops nummifer (jumping viper) from Costa Rica. Toxicon 1989; 27: 735–745.
- 16 Harris JB. Phospholipases in snake venoms and their effects on nerve and muscle. In: AL Harvey, editor. Snake toxins. New York: Pergamon Press; 1991. p 91–129.
- 17 Harris JB, MacDonell CA. Phospholipase A2 activity of notexin and its role in muscle damage. Toxicon 1981; 19: 419–430.
- 18 Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB. Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro preparations from rodents and chicks. Toxicon 1994; 32: 257–265.
- 19 Hudson BJ. The small-eyed snake (Micropechis ikaheka): a review of current knowledge. P N G Med J 1988; 31: 173–178.
- 20 Hudson BJ, Pomat K. Ten years of snake bite in Madang Province, Papua New Guinea. Trans R Soc Trop Med Hyg 1988; 82: 506–508.
- 21 Kini RM, Evans HJ. A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon 1989; 27: 613–635.
- 22 Krizaj I, Faure G, Gubensek F, Bon C. Neurotoxic phospholipases A2 ammodytoxin and crotoxin bind to distinct high-affinity protein acceptors in Torpedo marmorata electric organ. Biochemistry 1997; 36: 2779–2787.
- 23 Murrell G. The effectiveness of the pressure/immobilization first aid technique in the case of a tiger snake bite. Med J Aust 1981; 2: 295.
- 24 Nirthanan S, Gao R, Gopalakrishnakone P, Gwee MCE, Khoo HE, Cheah LS, et al. Pharmacological characterization of mikatoxin, an α-neurotoxin isolated from the venom of the New-Guinean small-eyed snake Micropechis ikaheka. Toxicon 2002; 40: 863–871.
- 25 Osman OH, Karrar MA. Acetylcholine release from the nerve terminals of the guinea-pig ileum by Naja venoms. Toxicon 1976; 14: 127–132.
- 26 Phillips RE, Theakston RD, Warrell DA, Galigedara Y, Abeysekera DT, Dissanayaka P, et al. Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med 1988; 68: 691–715.
- 27 Ramasamy S, Isbister GK, Hodgson WC. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation. Toxicon 2004; 44: 837–845.
- 28 Ritonja A, Gubensek F. Ammodytoxin A, a highly lethal phospholipase A2 from Vipera ammodytes ammodytes venom. Biochim Biophys Acta 1985; 828: 306–312.
- 29 Sket D, Gubensek F. Pharmacological study of phospholipase A from Vipera ammodytes venom. Toxicon 1976; 14: 393–396.
- 30 Soares AM, Andriao-Escarso SH, Bortoleto RK, Rodrigues-Simioni L, Arni RK, Ward RJ, et al. Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom. Arch Biochem Biophys 2001; 387: 188–196.
- 31 Soares AM, Guerra-Sá R, Borja-Oliveira CR, Rodrigues VM, Rodrigues-Simioni L, Rodrigues V, et al. Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A2 homologue from Bothrops neuwiedi pauloensis venom. Arch Biochem Biophys 2000; 378: 201–209.
- 32 Soares AM, Oshima-Franco Y, Vieira CA, Leite GB, Fletcher JE, Jiang MS, et al. Mn2+ ions reduce the enzymatic and pharmacological activities of bothropstoxin-I, a myotoxic Lys49 phospholipase A2 homologue from Bothrops jararacussu snake venom. Int J Biochem Cell Biol 2002; 34: 668–677.
- 33 Tibballs J, Kuruppu S, Hodgson WC, Carroll T, Hawdon G, Sourial M, et al. Cardiovascular, haematological and neurological effects of the venom of the Papua New Guinean small-eyed snake (Micropechis ikaheka) and their neutralisation with CSL polyvalent and black snake antivenoms. Toxicon 2003; 42: 647–655.
- 34 Tsai IH, Liu HC, Chang T. Toxicity domain in presynaptically toxic phospholipase A2 of snake venom. Biochim Biophys Acta 1987; 916: 94–99.
- 35 Volwerk JJ, Pieterson WA, de Haas GH. Histidine at the active site of phospholipase A2. Biochemistry 1974; 13: 1446–1454.
- 36 Warrell DA, Hudson BJ, Lalloo DG, Trevett AJ, Whitehead P, Bamler PR, et al. The emerging syndrome of envenoming by the New Guinea small-eyed snake Micropechis ikaheka. Q J Med 1996; 89: 523–530.
- 37 Wickramaratna JC, Fry BG, Aguilar MI, Kini RM, Hodgson WC. Isolation and pharmacological characterization of a phospholipase A2 myotoxin from the venom of the Irian Jayan death adder (Acanthophis rugosus). Br J Pharmacol 2003; 138: 333–342.
- 38 Wickramaratna JC, Hodgson WC. A pharmacological examination of venoms from three species of death adder (Acanthophis antarcticus, Acanthophis praelongus and Acanthophis pyrrhus). Toxicon 2001; 39: 209–216.
- 39 Worrell E. Reptiles of Australia. Sydney: Angus & Robertson; 1970.
- 40 Wrogemann K, Pena SD. Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet 1976; 1: 672–674.
Citing Literature
